Ignite Creation Date:
2024-05-06 @ 7:58 PM
Last Modification Date:
2024-10-26 @ 3:18 PM
Study NCT ID:
NCT06205329
Status:
COMPLETED
Last Update Posted:
2024-06-13
First Post:
2023-03-28
Brief Title:
Study of WPV01 in Healthy Subjects
Sponsor:
Westlake Pharmaceuticals Hangzhou Co Ltd
Organization:
Westlake Pharmaceuticals Hangzhou Co Ltd
Study Overview
Official Title:
Phase I Study on the Safety Tolerability Pharmacokinetics and Food Effect Evaluation of WPV01 and WPV01 Co-administrated Ritonavir in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase I Clinical Study to Evaluate the Safety Tolerability and Pharmacokinetics of WPV01 and WPV01 Co-administrated With Ritonavir in Healthy Adult Subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None